The benefit of atrial septal defect closure in elderly patients

Monika Komar1, Tadeusz Przewlocki1, Maria Olszowska1

  • 1Department of Cardiac and Vascular Diseases, Institute of Cardiology, Jagiellonian University, Krakow, Poland.

Insights

Transcatheter closure of atrial septal defects (ASDs) in patients over 60 significantly improves exercise capacity and quality of life. This percutaneous treatment is safe and effective, offering long-term clinical and hemodynamic benefits in the elderly.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Geriatric Cardiology

Background:

  • Atrial septal defects (ASDs) in elderly patients present a controversial treatment scenario.
  • Transcatheter closure is an alternative to surgical repair for ASDs.

Purpose of the Study:

  • To evaluate the outcomes of transcatheter closure for secundum ASDs in patients aged 60 years and older.
  • To assess improvements in exercise capacity, quality of life, and hemodynamic parameters post-procedure.

Main Methods:

  • Analysis of 75 patients (mean age 65.3 years) with isolated secundum ASDs undergoing transcatheter closure.
  • Pre- and post-procedure assessments included exercise tests, echocardiography, and the SF-36 Health Survey at 12 months.

Main Results:

  • Successful device implantation in all patients with no major complications.
  • Significant improvements in exercise time (P<0.001) and oxygen consumption (P<0.001) at 6 and 12 months.
  • Marked improvement in 7 of 8 SF-36 quality of life parameters and significant reduction in right heart dimensions.

Conclusions:

  • Transcatheter closure of ASDs in elderly patients leads to significant clinical and hemodynamic improvements.
  • These benefits are maintained during long-term follow-up, supporting the procedure's efficacy in older individuals.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
511
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
746
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
583
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
670
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.8K
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
409